New drug cocktail aims to wipe out bladder cancer before surgery

NCT ID NCT07693959

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether combining the targeted drug disitamab vedotin (RC48) with chemotherapy (gemcitabine) before surgery works as well as RC48 plus an immunotherapy (toripalimab) for people with HER2-positive muscle-invasive bladder cancer. Participants receive one of the two combos for 3–6 cycles, then undergo bladder removal surgery. The main goal is to see how many patients have no cancer left in the removed tissue. The study also tracks side effects and long-term outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Disitamab vedotin (RC48) and gemcitabine
What this could lead to
If successful, this combination could become a standard pre-surgery treatment for HER2-positive muscle-invasive bladder cancer, potentially increasing the chance of eliminating all cancer before surgery.
What could go wrong
This is an early-phase comparison; the experimental arm may not prove superior or even non-inferior to the comparator. Side effects from chemotherapy and targeted therapy can be significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIBC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center

    RECRUITING

    Shenzhen, Guangdong, 518117, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    RECRUITING

    Wuhan, Hubei, 430030, China

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Fujian Medical University Union Hospital

    RECRUITING

    Fuzhou, Fujian, 350001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Huanggang Central Hospital

    RECRUITING

    Huanggang, Hubei, 438000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Huangshi Central Hospital

    RECRUITING

    Huangshi, Hubei, 435000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, Hubei, 430079, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Jiangxi Provincial People's Hospital

    RECRUITING

    Nanchang, Jiangxi, 330006, China

    Contact Phone: •••-•••-••••

    Contact

  • Jingmen Central Hospital

    RECRUITING

    Jingmen, Hubei, 448000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Jingzhou Central Hospital

    RECRUITING

    Jingzhou, Hubei, 434020, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Jingzhou First People's Hospital

    RECRUITING

    Jingzhou, Hubei, 434000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Renmin Hospital of Wuhan University

    RECRUITING

    Wuhan, Hubei, 430060, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Shandong Cancer Hospital and Institute

    RECRUITING

    Jinan, Shandong, 250117, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Taihe Hospital

    RECRUITING

    Shiyan, Hubei, 442000, China

    Contact Phone: •••-•••-••••

    Contact

  • The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture

    RECRUITING

    Enshi, Hubei, 445000, China

    Contact Phone: •••-•••-••••

    Contact

  • The Central Hospital of Wuhan

    RECRUITING

    Wuhan, Hubei, 430014, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The First Affiliated Hospital of Anhui Medical University

    RECRUITING

    Hefei, Anhui, 230022, China

    Contact Phone: •••-•••-••••

    Contact

  • The First Affiliated Hospital of Xiamen University

    RECRUITING

    Xiamen, Fujian, 361003, China

    Contact Phone: •••-•••-••••

    Contact

  • Wuhan No.1 Hospital

    RECRUITING

    Wuhan, Hubei, 430022, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Xiangyang Central Hospital

    RECRUITING

    Xiangyang, Hubei, 441021, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yichang Central People's Hospital

    RECRUITING

    Yichang, Hubei, 443003, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Zhongnan Hospital of Wuhan University

    RECRUITING

    Wuhan, Hubei, 430071, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Zhujiang Hospital of Southern Medical University

    RECRUITING

    Guangzhou, Guangdong, 510280, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.